← All companies

CAPR

Capricor Therapeutics, Inc.

CAPR Nasdaq Pharmaceutical Preparations EDGAR ↗

$4.20

+0.01 +0.24%

Key statistics

from XBRL data in SEC filings

Market cap

$243M

Revenue (TTM)

$22.3M

Net income (TTM)

-$115M

EPS (TTM)

$-2.32

P/E ratio

—

Dividend yield

—

Free cash flow

-$72.7M

Cash

$105M

Total assets

$326M

Gross margin

—

52-week range

$2.96 – $40.37

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 30, 2026 8-K Other events Jul 29, 2026 8-K Entered a material agreement; Took on a direct financial obligation Jul 14, 2026 8-K Other events Jun 26, 2026 8-K Shareholder vote results Jun 8, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Regulation FD disclosure; Other events May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 17, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Regulation FD disclosure; Other events Mar 10, 2026 8-K Regulation FD disclosure; Other events Dec 5, 2025 8-K Regulation FD disclosure Dec 3, 2025 8-K Regulation FD disclosure; Other events Dec 3, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Regulation FD disclosure Jul 11, 2025 8-K Director or officer change; Shareholder vote results May 27, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Director or officer change Apr 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 26, 2025 8-K Results of operations (earnings release) Mar 19, 2025 8-K Regulation FD disclosure Mar 4, 2025 8-K Other events Jan 2, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Entered a material agreement; Regulation FD disclosure Oct 17, 2024 8-K Results of operations (earnings release); Other events Oct 16, 2024 8-K Regulation FD disclosure; Other events Oct 9, 2024 8-K Regulation FD disclosure Sep 24, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Sep 17, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Amended charter or bylaws May 15, 2024 8-K Shareholder vote results May 15, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 13, 2024